|
envenomation resulting in negative regulation of voltage-gated potassium channel activity in other organism
|
GO_0044562 |
|
|
envenomation resulting in slowing of activation kinetics of voltage-gated potassium channel in other organism
|
GO_0044563 |
|
|
envenomation resulting in occlusion of the pore of voltage-gated potassium channel in other organism
|
GO_0044564 |
|
|
dendritic cell proliferation
|
GO_0044565 |
|
|
lymphocyte proliferation
|
GO_0046651 |
|
|
chondrocyte activation
|
GO_0044566 |
|
|
primary cell wall cellulose synthase complex
|
GO_0044567 |
|
|
iron-sulfur-molybdenum cofactor assembly
|
GO_0044593 |
|
|
17-beta-hydroxysteroid dehydrogenase (NAD+) activity
|
GO_0044594 |
|
|
estradiol 17-beta-dehydrogenase activity
|
GO_0004303 |
|
|
decaprenyldihydroxybenzoate methyltransferase activity
|
GO_0044595 |
|
|
3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity
|
GO_0010420 |
|
|
3-demethylubiquinol-10 3-O-methyltransferase activity
|
GO_0044596 |
|
|
3-demethylubiquinol-n 3-O-methyltransferase activity
|
GO_0061542 |
|
|
S-adenosylmethionine-dependent methyltransferase activity
|
GO_0008757 |
|
|
daunorubicin metabolic process
|
GO_0044597 |
|
|
quinone metabolic process
|
GO_1901661 |
|
|
aminoglycoside antibiotic metabolic process
|
GO_0030647 |
|
|
polyketide metabolic process
|
GO_0030638 |
|
|
doxorubicin metabolic process
|
GO_0044598 |
|
